Search tips
Search criteria 


Logo of jclinpathJournal of Clinical PathologyVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Clin Pathol. 1987 August; 40(8): 909–913.
PMCID: PMC1141135

Some long term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell Collaborative Surveys.


Data from two community studies on men from South Wales and the west of England suggest that the effects of smoking on the haemostatic system remain for many years after giving up. Long term correlations between several variables, including plasma fibrinogen and white cell count, and the length of time after giving up were seen in ex-smokers. Dose response relations were apparent in current smokers in terms of the white cell count and two haematological variables, the packed and mean cell volumes. These long term correlations probably reflect the toxicity of other agents in tobacco smoke besides nicotine and carbon monoxide, which act only in the short term. Identification of these agents may further our understanding of the mechanism by which cigarette smoking is associated with atherosclerotic disease.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (740K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Kolars JC, Levitt MD, Aouji M, Savaiano DA. Yogurt--an autodigesting source of lactose. N Engl J Med. 1984 Jan 5;310(1):1–3. [PubMed]
  • Meade TW, North WR, Chakrabarti R, Stirling Y, Haines AP, Thompson SG, Brozovié M. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980 May 17;1(8177):1050–1054. [PubMed]
  • Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984 Aug 23;311(8):501–505. [PubMed]
  • Yarnell JW, Sweetnam PM, Elwood PC, Eastham R, Gilmour RA, O'Brien JR, Etherington MD. Haemostatic factors and ischaemic heart disease. The Caerphilly study. Br Heart J. 1985 May;53(5):483–487. [PMC free article] [PubMed]
  • Meade TW, Chakrabarti R, Haines AP, North WR, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J. 1979 Jan 20;1(6157):153–156. [PMC free article] [PubMed]
  • Reid DD, Hamilton PJ, McCartney P, Rose G, Jarrett RJ, Keen H. Smoking and other risk factors for coronary heart-disease in British civil servants. Lancet. 1976 Nov 6;2(7993):979–984. [PubMed]
  • Kannel WB. Update on the role of cigarette smoking in coronary artery disease. Am Heart J. 1981 Mar;101(3):319–328. [PubMed]
  • Thorp JM, Horsfall GB, Stone MC. A new red-sensitive micronephelometer. Med Biol Eng. 1967 Jan;5(1):51–56. [PubMed]
  • CLAUSS A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957 Apr;17(4):237–246. [PubMed]
  • Harkness J. The viscosity of human blood plasma; its measurement in health and disease. Biorheology. 1971 Dec;8(3):171–193. [PubMed]
  • O'Brien JR, Etherington M, Jamieson S, Lawford P, Sussex J, Lincoln SV. Heparin neutralizing activity test in the diagnosis of acute myocardial infarction. J Clin Pathol. 1975 Dec;28(12):975–979. [PMC free article] [PubMed]
  • Baker IA, Eastham R, Elwood PC, Etherington M, O'Brien JR, Sweetnam PM. Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study. Br Heart J. 1982 May;47(5):490–494. [PMC free article] [PubMed]
  • Yarnell JW, Fehily AM, Milbank J, Kubicki AJ, Eastham R, Hayes TM. Determinants of plasma lipoproteins and coagulation factors in men from Caerphilly, South Wales. J Epidemiol Community Health. 1983 Jun;37(2):137–140. [PMC free article] [PubMed]
  • Lowe GD, Drummond MM, Forbes CD, Barbenel JC. The effects of age and cigarette-smoking on blood and plasma viscosity in men. Scott Med J. 1980 Jan;25(1):13–17. [PubMed]
  • Hill P, Haley NJ, Wynder EL. Cigarette smoking: carboxyhemoglobin, plasma nicotine, cotinine and thiocyanate vs self-reported smoking data and cardiovascular disease. J Chronic Dis. 1983;36(6):439–449. [PubMed]
  • Galea G, Davidson RJ. Haematological and haemorheological changes associated with cigarette smoking. J Clin Pathol. 1985 Sep;38(9):978–984. [PMC free article] [PubMed]
  • Kaufman DW, Helmrich SP, Rosenberg L, Miettinen OS, Shapiro S. Nicotine and carbon monoxide content of cigarette smoke and the risk of myocardial infarction in young men. N Engl J Med. 1983 Feb 24;308(8):409–413. [PubMed]
  • McGill HC., Jr Potential mechanisms for the augmentation of atherosclerosis and atherosclerotic disease by cigarette smoking. Prev Med. 1979 May;8(3):390–403. [PubMed]
  • Hartz AJ, Anderson AJ, Brooks HL, Manley JC, Parent GT, Barboriak JJ. The association of smoking with cardiomyopathy. N Engl J Med. 1984 Nov 8;311(19):1201–1206. [PubMed]
  • Pilgeram LO. Turnover rate of autologous plasma fibrinogen-14C in subjects with coronary thrombosis. Thromb Diath Haemorrh. 1968 Nov 15;20(1):31–43. [PubMed]
  • Lewis GP, Jusko WJ, Coughlin LL. Cadmium accumulation im man: influence of smoking, occupation, alcoholic habit and disease. J Chronic Dis. 1972 Dec;25(12):717–726. [PubMed]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group